In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


altona Diagnostics GmbH

Latest From altona Diagnostics GmbH

More German Companies Get To Work On COVID-19 Diagnostic Test Development

Another three in vitro diagnostics companies in Germany are working on tests for the early detection of COVID-19, with confirmed infections reaching 89,000 globally by 2 March.

Germany Policy

FDA Clears Another Zika Assay, Luminex's xMap

The xMap Multiflex Zika RNA Assay is a molecular diagnostic that is designed to detect the Zika virus in human serum, urine or plasma.

Medical Device United States

Manufacturer Doesn’t Expect Zika Blood-Screening Test Shortage

US FDA has asked Miami-area blood banks to close until they can screen all blood supplies for the Zika virus in the wake of the first known cases transmitted by mosquitos within the US. A manufacturer of the only test currently available for blood-bank use does not expect shortages, despite the increased demand.

Infectious Diseases In Vitro Diagnostics

Deal To Fight Zika Virus Boosts NIH, CDC Efforts, But Offers No FDA Review Dollars

A $1.1bn agreement between the House and Senate to fund the emergency Zika virus response gives millions of dollars to the Centers for Disease Control and Prevention, NIH, and HHS's biodefense unit, but leaves FDA with no extra funds to support reviews of Zika products. The deal would take dollars from Ebola funding and HHS Affordable Care Act efforts as an offset, and is opposed by the president, who says he will veto it.

Medical Device Legislation
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • altona Diagnostics GmbH
  • Senior Management
  • Ulrich Spengler, Managing Dir.
  • Contact Info
  • altona Diagnostics GmbH
    Phone: 40 548 06 76 0
    Mörkenstr. 12
    Hamburg, 22767